World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
63
Citations
14819
World Ranking
10183
National Ranking
4448

Emmett V. Schmidt publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Emmett V. Schmidt sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 184 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Emmett V. Schmidt D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Emmett V. Schmidt sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 63 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Emmett V. Schmidt is affiliated with MSD (United States) and has developed a research portfolio primarily within the field of Medicine, with a strong focus on Oncology. Their work spans several subfields including Oncology, Immunology, Pulmonary and Respiratory Medicine, Molecular Biology, and Surgery.

The scientist's research interests center primarily on cancer-related topics. Major areas of work include Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research, CAR-T Cell Therapy Research, Renal Cell Carcinoma Treatment, Computational Drug Discovery Methods, Endometrial and Cervical Cancer Treatments, and Immunotherapy and Immune Responses.

Frequent coauthors collaborating with Emmett V. Schmidt include:

  • Allen Lee Cohn
  • Matthew H. Taylor
  • Marcia S. Brose
  • Corina E. Dutcus
  • Jane Wu

The scientist's publications appear most often in the following venues:

  • Journal of Clinical Oncology
  • Regular and Young Investigator Award Abstracts
  • Contemporary Clinical Trials
  • Journal for ImmunoTherapy of Cancer
  • The Lancet Oncology

Notable recent papers published by Emmett V. Schmidt include:

  • Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer, 2020, Journal of Clinical Oncology
  • Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study, 2021, The Lancet Oncology
  • Drug independence and the curability of cancer by combination chemotherapy, 2022, Trends in cancer
  • MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses, 2020, Science
  • Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti-PD-(L)1 Therapy, 2020, Clinical Cancer Research

Best Publications

  • Mammary Hyperplasia and Carcinoma in MMTV-cyclin D1 Transgenic Mice

    Timothy C. Wang;Robert D. Cardiff;Lawrence Zukerberg;Emma Lees

  • IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development

    Yixue Cao;Giuseppina Bonizzi;Tiffany N. Seagroves;Florian R. Greten

  • The role of c-myc in cellular growth control.

    Emmett V Schmidt

  • Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial.

    Vicky Makker;Drew Rasco;Nicholas J Vogelzang;Marcia S Brose

  • Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

    Vicky Makker;Matthew H. Taylor;Carol Aghajanian;Ana Oaknin

  • Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E

    I B Rosenwald;A Lazaris-Karatzas;N Sonenberg;E V Schmidt

  • Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc

    Igor B. Rosenwald;David B. Rhoads;Lawrence D. Callanan;Kurt J. Isselbacher

  • Eukaryotic Translation Initiation Factor 4E Regulates Expression of Cyclin D1 at Transcriptional and Post-transcriptional Levels

    Igor B. Rosenwald;Roger Kaspar;Dennis Rousseau;Lee Gehrke

  • Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells.

    Goshi Shiota;David B. Rhoads;Timothy C. Wang;Toshikazu Nakamura

  • SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study

    Antoni Ribas;Theresa Medina;Shivaani Kummar;Asim Amin

  • The cytomegalovirus enhancer: a pan-active control element in transgenic mice.

    E V Schmidt;G Christoph;R Zeller;P Leder

  • Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)

    Tara C Mitchell;Omid Hamid;David C Smith;Todd M Bauer

  • Coupling of cell division to cell growth by translational control of the G1 cyclin CLN3 in yeast

    Michael Polymenis;Emmett V. Schmidt

  • Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 (enkephalinase): direct evidence by cDNA transfection analysis

    Margaret A. Shipp;Jayanthi Vijayaraghavan;Emmett V. Schmidt;Emma L. Masteller

  • Viral RNA Mutations Are Region Specific and Increased by Ribavirin in a Full-Length Hepatitis C Virus Replication System

    Ana Maria Contreras;Yoichi Hiasa;Wenping He;Adam Terella

  • An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc.

    R M Jones;J Branda;K A Johnston;M Polymenis

  • Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice

    Yasuo Imanishi;Yoshitaka Hosokawa;Katsuhiko Yoshimoto;Katsuhiko Yoshimoto;Ernestina Schipani

  • The role of c-myc in regulation of translation initiation.

    Emmett V Schmidt

  • Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors.

    Anthony W. Tolcher;Mario Sznol;Siwen Hu-Lieskovan;Kyriakos P. Papadopoulos

  • Hepatitis C Virus Expression Suppresses Interferon Signaling by Degrading STAT1

    Wenyu Lin;Won Hyeok Choe;Yoichi Hiasa;Yoshitaka Kamegaya

Frequent Co-Authors

Raymond T. Chung
Raymond T. Chung Harvard University
Timothy C. Wang
Timothy C. Wang Columbia University
Philip Leder
Philip Leder Harvard University
Nicholas J. Vogelzang
Nicholas J. Vogelzang University of Nevada Reno
Toshikazu Nakamura
Toshikazu Nakamura Osaka University
Antoni Ribas
Antoni Ribas University of California, Los Angeles
James W. Mier
James W. Mier Beth Israel Deaconess Medical Center
Thomas F. Gajewski
Thomas F. Gajewski University of Chicago
Dmitry I. Gabrilovich
Dmitry I. Gabrilovich AstraZeneca (United Kingdom)
Kazue Takahashi
Kazue Takahashi Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Emmett V. Schmidt

Trending Scientists

Recently Published Articles